Back to today’s briefing

Story perspectives

Ravgen Wins Patent Battle Against Labcorp in Court

1/7/2025

43 9

Summary

Story summary

In a significant legal victory for Ravgen, the U.S. Court of Appeals upheld the Patent Trial and Appeal Board's ruling against Labcorp's challenge to its non-invasive DNA sampling patent. The court determined that Labcorp could not demonstrate the obviousness of the patent claims, reinforcing the Board's thorough examination of prior art and the rationale behind combining methods.

1 of 1

Story summary

In a significant legal victory for Ravgen, the U.S. Court of Appeals upheld the Patent Trial and Appeal Board's ruling against Labcorp's challenge to its non-invasive DNA sampling patent. The court determined that Labcorp could not demonstrate the obviousness of the patent claims, reinforcing the Board's thorough examination of prior art and the rationale behind combining methods.